(Q43593864)

English

The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma

scientific article published in November 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

positron emission tomography

1 reference

based on heuristic

inferred from title

12

object named as

Jaffer A Ajani

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Wayne L. Hofstetter

6

object named as

Wayne Hofstetter

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Stephen Swisher

9

object named as

Stephen G Swisher

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Manoop S Bhutani

8

object named as

Manoop S Bhutani

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

7

object named as

Dipen Maru

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

2

object named as

Lianchun Xiao

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

object named as

Zhongxing Liao

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Homer A Macapinlac

10

object named as

Homer Macapinlac

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

3

object named as

Eric Rohren

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1

object named as

Heta Javeri

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Jeffrey H Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Xuemei Wang

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5184-5192

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Translating insights from the cancer genome into clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

The cancer biomarker problem

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Enabling personalized cancer medicine through analysis of gene-expression patterns

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

The importance of PET in the diagnosis and response evaluation of esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Classification of adenocarcinoma of the oesophagogastric junction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Dissecting the metastatic cascade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Detection, clinical relevance and specific biological properties of disseminating tumour cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

[18F-FDG-PET in therapy response of esophageal cancer].

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Imaging in the era of molecular oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

Are patients with esophageal cancer who become PET negative after neoadjuvant chemoradiation free of cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

21 January 2018

The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

FDG-PET lymphoma demonstration project invitational workshop

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24604

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24604

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43593864&oldid=2101761871"